Survival Rate without Brain Abnormalities on Postnatal Ultrasonography among Monochorionic Twins after Fetoscopic Laser Photocoagulation for Selective Intrauterine Growth Restriction with Concomitant Oligohydramnios.


Journal

Fetal diagnosis and therapy
ISSN: 1421-9964
Titre abrégé: Fetal Diagn Ther
Pays: Switzerland
ID NLM: 9107463

Informations de publication

Date de publication:
2019
Historique:
received: 13 10 2017
accepted: 05 12 2017
pubmed: 21 2 2018
medline: 23 4 2019
entrez: 21 2 2018
Statut: ppublish

Résumé

We aimed to clarify the survival rate without brain abnormalities (BA) after fetoscopic laser photoco-agulation (FLP) for monochorionic diamniotic twin gestations (MCDA) with selective intrauterine growth restriction (sIUGR) accompanied by abnormal umbilical artery (UA) Doppler waveforms and isolated oligohydramnios in the sIUGR twin. This retrospective study included 52 cases that underwent FLP. The main outcome was survival rate without BA of the twins at age 28 days. BA was defined as severe intraventricular hemorrhage and periventricular leukomalacia on postnatal ultrasonography. Median gestational age at FLP was 20 (16-24) weeks. Ten cases were classified as type III based on Doppler for the UA. For all cases, including 20 cases of anterior placenta, FLP was completed without major intraoperative complications. Amnioinfusion was required in 49 cases for better fetoscopic visualization. Fetal loss occurred in 29 sIUGR twins and two larger twins, whereas one larger twin experienced neonatal death. Survival rates without BA were 44% (n = 23) for sIUGR twins and 94% (n = 49) for the larger twins. FLP for MCDA with sIUGR presenting with oligohydramnios in the sIUGR twin might be considered a prenatal treatment option.

Identifiants

pubmed: 29462812
pii: 000486130
doi: 10.1159/000486130
doi:

Types de publication

Journal Article Multicenter Study Twin Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

21-27

Informations de copyright

© 2018 S. Karger AG, Basel.

Auteurs

Keisuke Ishii (K)

Department of Maternal Fetal Medicine, Osaka Women's and Children Hospital, Izumi, Japankeisui@mch.pref.osaka.jp.

Seiji Wada (S)

Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan.

Mayumi Takano (M)

Department of Obstetrics and Gynecology, Toho University Omori Medical Center, Tokyo, Japan.
Department of Obstetrics and Gynecology, Kawasaki Medical University, Okayama, Japan.

Masahiko Nakata (M)

Department of Obstetrics and Gynecology, Toho University Omori Medical Center, Tokyo, Japan.
Department of Obstetrics and Gynecology, Kawasaki Medical University, Okayama, Japan.

Takeshi Murakoshi (T)

Department of Perinatology, Maternal and Perinatal Care Center, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.

Haruhiko Sago (H)

Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH